Overview

Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To study the activity and toxicity of a neoadjuvant regimen including high-dose ifosfamide in combination with radiotherapy, and subsequent surgery, in high-risk soft tissue sarcomas.
Phase:
Phase 2
Details
Lead Sponsor:
Grupo Espanol de Investigacion en Sarcomas
Treatments:
Ifosfamide
Isophosphamide mustard